$AMRZ

Amrize names Samuel J. Poletti as CFO as Baris Oran steps down

Amrize Ltd (AMRZ) appointed Samuel J. Poletti as CFO, effective August 24, 2026, replacing Baris Oran, who is stepping down for personal reasons. Poletti, 45, previously served as Chief Strategy and M&A Officer at Amrize and held roles at Holcim. Oran will remain an employee until August 24, 2027, per a 12-month notice period.

Original reporting
Published Aug 24, 2026, 9:03 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 6:41 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$AMRZ
Neutral
medium confidence
Mentioned
$AMRZ
Relevance
7/10
alphai data visualization · based on tradingview.com
Decision brief

The 30-second read

$AMRZNeutralLow
01

Why it matters

The appointment is a standard corporate governance update with limited immediate market impact.

02

Market read

Executive change news; modest relevance for traders monitoring Amrize.

03

What to watch

Baris Oran's departure terms and Poletti's Holcim M&A background may influence future acquisitions.

Relevance 7/10Novelty 6/10Timing: effective Aug 24, 2026

Background

Amrize Ltd disclosed the CFO appointment via an SEC 8‑K filing.

Company-level read

Ticker impact

$AMRZNeutralMedium confidence
Context

Amrize Ltd filed an 8‑K announcing Samuel J. Poletti as new CFO, replacing Baris Oran.

Expected impact

minor short‑term volatility, limited directional bias

Evidence & confidence

Executive changes are material but not price‑driving without additional context.

Market effects

May signal strategic focus for Amrize's sector, but limited spillover.

US‑listed company; minimal regional effect.

Low global relevance.

Counterpoint

CFO change could be a catalyst for a strategic shift, offering upside if new initiatives succeed.

Key entities

  • Samuel J. Poletti

    New Chief Financial Officer of Amrize Ltd.

  • Baris Oran

    Outgoing CFO of Amrize Ltd.

Related articles

$AMRZMedAI 8/10

Amrize (AMRZ) Q2 2026 Earnings Call Transcript

Amrize AG (AMRZ) reported Q2 2026 revenue of $3.49B, up 8.6%, and net income of $476M, up 14.4%, with adjusted EBITDA of $986M. Management raised fiscal 2026 revenue guidance to $12.5B-$12.7B but revised adjusted EBITDA to $3.1B-$3.2B due to oil-driven cost inflation. The company cited data center and infrastructure demand.

$AMRZMedAI 8/10

Amrize Q2 EPS misses $0.94 estimate as costs weigh on margins

Amrize (NYSE: AMRZ) reported Q2 2026 adjusted EPS of $0.88, below the $0.94 consensus estimate. Revenue rose 8.51% to $3.494 billion, beating the $3.365 billion expectation. Net income increased 14.4% to $476 million. The company raised FY2026 revenue guidance to $12.5B-$12.7B but lowered adjusted EBITDA guidance to $3.1B-$3.2B due to cost inflation.

$AMRZMed

RBC Downgrades Amrize After A Rare Q2 Miss

RBC downgraded Amrize after a rare Q2 miss and reduced guidance, citing a timing mismatch between input-cost increases and the full pass-through of surcharges and price hikes. RBC cut 2026-2028 EBITDA estimates by 4%, 6%, and 7% and EPS by 12%, 14%, and 15%, lowering its stock rating to underperform and price target to $48 from $60.